{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:22:15Z","timestamp":1751430135860,"version":"3.41.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health and Aged Care, Australian Government","doi-asserted-by":"publisher","award":["FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047"],"award-info":[{"award-number":["FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047","FSPGN000047"]}],"id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03190-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:09:34Z","timestamp":1751400574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and verification of a novel tiling PCR method for long-range HIV-1 sequencing in a diagnostic setting"],"prefix":"10.1038","volume":"15","author":[{"given":"Bethany A.","family":"Horsburgh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunasingam","family":"Abayasingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S. P.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lachlan","family":"Coin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D.","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan","family":"van Hal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowena A.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Di Giallonardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The H2Seq Genome Sequencing Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Castley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sevendal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaturaka","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Chibo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloise","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Taiaroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen","family":"Kok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolene","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Dragasevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Caly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon Patrick","family":"McNally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lex","family":"Leong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark W.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Turra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"3190_CR1","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1016\/S2352-3018(18)30132-2","volume":"5","author":"BR Bavinton","year":"2018","unstructured":"Bavinton, B. R. et al. Viral suppression and HIV transmission in serodiscordant male couples: An international, prospective, observational, cohort study. Lancet HIV 5, e438\u2013e447 (2018).","journal-title":"Lancet HIV"},{"key":"3190_CR2","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/S0140-6736(19)30418-0","volume":"393","author":"AJ Rodger","year":"2019","unstructured":"Rodger, A. J. et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): Final results of a multicentre, prospective, observational study. The Lancet 393, 2428\u20132438 (2019).","journal-title":"The Lancet"},{"key":"3190_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen, M. S. et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N. Engl. J. Med. 375, 830\u2013839 (2016).","journal-title":"N. Engl. J. Med."},{"key":"3190_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29273","volume":"95","author":"F Jenkins","year":"2023","unstructured":"Jenkins, F. et al. Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory. J. Med. Virol. 95, e29273 (2023).","journal-title":"J. Med. Virol."},{"key":"3190_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12981-021-00390-8","volume":"18","author":"A Ayitewala","year":"2021","unstructured":"Ayitewala, A., Ssewanyana, I. & Kiyaga, C. Next generation sequencing based in-house HIV genotyping method: Validation report. AIDS Res. Ther. 18, 64 (2021).","journal-title":"AIDS Res. Ther."},{"key":"3190_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jviromet.2009.03.021","volume":"159","author":"S Saravanan","year":"2009","unstructured":"Saravanan, S. et al. Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq\u2122 2.0 and an in-house method. J. Virol. Methods 159, 211\u2013216 (2009).","journal-title":"J. Virol. Methods"},{"key":"3190_CR7","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/j.csbj.2023.03.038","volume":"21","author":"Y Ni","year":"2023","unstructured":"Ni, Y., Liu, X., Simeneh, Z. M., Yang, M. & Li, R. Benchmarking of Nanopore R10.4 and R9.4.1 flow cells in single-cell whole-genome amplification and whole-genome shotgun sequencing. Comput. Struct. Biotechnol. J. 21, 2352\u20132364 (2023).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"3190_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41587-023-01750-7","volume":"42","author":"S Arslan","year":"2024","unstructured":"Arslan, S. et al. Sequencing by avidity enables high accuracy with low reagent consumption. Nat. Biotechnol. 42, 132\u2013138 (2024).","journal-title":"Nat. Biotechnol."},{"key":"3190_CR9","doi-asserted-by":"publisher","first-page":"bpaa014","DOI":"10.1093\/biomethods\/bpaa014","volume":"5","author":"NE Freed","year":"2020","unstructured":"Freed, N. E., Vlkov\u00e1, M., Faisal, M. B. & Silander, O. K. Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding. Biol. Methods Protoc. 5, bpaa014 (2020).","journal-title":"Biol. Methods Protoc."},{"key":"3190_CR10","doi-asserted-by":"publisher","unstructured":"Tyson, J. R. et al. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv 2020.09.04.283077 (2020) https:\/\/doi.org\/10.1101\/2020.09.04.283077.","DOI":"10.1101\/2020.09.04.283077"},{"key":"3190_CR11","doi-asserted-by":"publisher","first-page":"e00649","DOI":"10.1128\/JCM.00649-21","volume":"59","author":"J Plitnick","year":"2021","unstructured":"Plitnick, J. et al. Whole-genome sequencing of SARS-CoV-2: Assessment of the ion torrent ampliseq panel and comparison with the Illumina MiSeq ARTIC protocol. J. Clin. Microbiol. 59, e00649-e721 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"3190_CR12","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1038\/s41467-020-20075-6","volume":"11","author":"RA Bull","year":"2020","unstructured":"Bull, R. A. et al. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis. Nat. Commun. 11, 6272 (2020).","journal-title":"Nat. Commun."},{"key":"3190_CR13","doi-asserted-by":"publisher","first-page":"1133407","DOI":"10.3389\/fmicb.2023.1133407","volume":"14","author":"A Temereanca","year":"2023","unstructured":"Temereanca, A. & Ruta, S. Strategies to overcome HIV drug resistance-current and future perspectives. Front. Microbiol. 14, 1133407 (2023).","journal-title":"Front. Microbiol."},{"key":"3190_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/v12040415","volume":"12","author":"H Jin","year":"2020","unstructured":"Jin, H., Li, D., Lin, M. H., Li, L. & Harrich, D. Tat-based therapies as an adjuvant for an HIV-1 functional cure. Viruses 12, 415 (2020).","journal-title":"Viruses"},{"key":"3190_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.70001","volume":"34","author":"BA Horsburgh","year":"2024","unstructured":"Horsburgh, B. A. et al. Next-generation sequencing methods for near-real-time molecular epidemiology of HIV and HCV. Rev. Med. Virol. 34, e70001 (2024).","journal-title":"Rev. Med. Virol."},{"key":"3190_CR16","doi-asserted-by":"publisher","first-page":"6227","DOI":"10.1038\/s41598-019-42417-1","volume":"9","author":"AE Obasa","year":"2019","unstructured":"Obasa, A. E., Engelbrecht, S. & Jacobs, G. B. Near full-length HIV-1 subtype B sequences from the early South African epidemic, detecting a BD unique recombinant form (URF) from a sample in 1985. Sci. Rep. 9, 6227 (2019).","journal-title":"Sci. Rep."},{"key":"3190_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12879-021-05905-2","volume":"21","author":"AE Obasa","year":"2021","unstructured":"Obasa, A. E., Ambikan, A. T., Gupta, S., Neogi, U. & Jacobs, G. B. Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa. BMC Infect. Dis. 21, 214 (2021).","journal-title":"BMC Infect. Dis."},{"key":"3190_CR18","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/COH.0000000000000344","volume":"12","author":"UM Parikh","year":"2017","unstructured":"Parikh, U. M., McCormick, K., van Zyl, G. & Mellors, J. W. Future technologies for monitoring HIV drug resistance and cure. Curr. Opin. HIV AIDS 12, 182\u2013189 (2017).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"3190_CR19","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1473-3099(13)70066-5","volume":"13","author":"AD Redd","year":"2013","unstructured":"Redd, A. D., Quinn, T. C. & Tobian, A. A. R. Frequency and implications of HIV superinfection. Lancet Infect. Dis. 13, 622\u2013628 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"3190_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.virusres.2016.10.019","volume":"239","author":"M Casadell\u00e0","year":"2017","unstructured":"Casadell\u00e0, M. & Paredes, R. Deep sequencing for HIV-1 clinical management. Virus Res. 239, 69\u201381 (2017).","journal-title":"Virus Res."},{"key":"3190_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25193","volume":"21","author":"H Ji","year":"2018","unstructured":"Ji, H. et al. Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: The Winnipeg Consensus. J. Int. AIDS Soc. 21, e25193 (2018).","journal-title":"J. Int. AIDS Soc."},{"key":"3190_CR22","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/v12060586","volume":"12","author":"H Ji","year":"2020","unstructured":"Ji, H. et al. Are we ready for NGS HIV drug resistance testing? The second \u2018Winnipeg Consensus\u2019 symposium. Viruses 12, 586 (2020).","journal-title":"Viruses"},{"key":"3190_CR23","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nprot.2017.066","volume":"12","author":"J Quick","year":"2017","unstructured":"Quick, J. et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat. Protoc. 12, 1261\u20131276 (2017).","journal-title":"Nat. Protoc."},{"key":"3190_CR24","unstructured":"Metrichor & Oxford Nanopore Technologies. EPI2ME. https:\/\/labs.epi2me.io\/ (2024)."},{"key":"3190_CR25","unstructured":"HIVREsnet. WHO HIVResNet HIV Drug Resistance Laboratory Operational Framework. (2020)."},{"key":"3190_CR26","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/S0140-6736(13)62187-X","volume":"383","author":"ENCORE1 Study Group","year":"2014","unstructured":"ENCORE1 Study Group. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial. The Lancet 383, 1474\u20131482 (2014).","journal-title":"The Lancet"},{"key":"3190_CR27","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/S0140-6736(13)61164-2","volume":"381","author":"SECOND-LINE Study Group","year":"2013","unstructured":"SECOND-LINE Study Group. Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): A randomised, open-label, non-inferiority study. The Lancet 381, 2091\u20132099 (2013).","journal-title":"The Lancet"},{"key":"3190_CR28","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3390\/v12121402","volume":"12","author":"F Di Giallonardo","year":"2020","unstructured":"Di Giallonardo, F. et al. Increased HIV subtype diversity reflecting demographic changes in the HIV epidemic in new south wales, Australia. Viruses 12, 1402 (2020).","journal-title":"Viruses"},{"key":"3190_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170601","volume":"12","author":"A Castley","year":"2017","unstructured":"Castley, A. et al. A national study of the molecular epidemiology of HIV-1 in Australia 2005\u20132012. PLoS ONE 12, e0170601 (2017).","journal-title":"PLoS ONE"},{"key":"3190_CR30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.celrep.2017.09.081","volume":"21","author":"B Hiener","year":"2017","unstructured":"Hiener, B. et al. Identification of genetically intact HIV-1 proviruses in specific CD4+ T cells from effectively treated participants. Cell Rep. 21, 813\u2013822 (2017).","journal-title":"Cell Rep."},{"key":"3190_CR31","unstructured":"Sanders-Buell, E., Salminen, M. & McCutchan, F. Sequencing primers for HIV-1. Human retroviruses and AIDS (1995)."},{"key":"3190_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104243","volume":"81","author":"AC Chrysostomou","year":"2020","unstructured":"Chrysostomou, A. C., Topcu, C., Stylianou, D. C., Hezka, J. & Kostrikis, L. G. Development of a new comprehensive HIV-1 genotypic drug resistance assay for all commercially available reverse transcriptase, protease and integrase inhibitors in patients infected with group M HIV-1 strains. Infect. Genet. Evol. 81, 104243 (2020).","journal-title":"Infect. Genet. Evol."},{"key":"3190_CR33","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1086\/503914","volume":"42","author":"TF Liu","year":"2006","unstructured":"Liu, T. F. & Shafer, R. W. Web resources for HIV Type 1 genotypic-resistance test interpretation. Clin. Infect. Dis. 42, 1608\u20131618 (2006).","journal-title":"Clin. Infect. Dis."},{"key":"3190_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature16996","volume":"530","author":"J Quick","year":"2016","unstructured":"Quick, J. et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 530, 228\u2013232 (2016).","journal-title":"Nature"},{"key":"3190_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12879-023-08423-5","volume":"23","author":"A Yakovleva","year":"2023","unstructured":"Yakovleva, A. et al. Hepatitis C Virus in people with experience of injection drug use following their displacement to Southern Ukraine before 2020. BMC Infect. Dis. 23, 446 (2023).","journal-title":"BMC Infect. Dis."},{"key":"3190_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12977-015-0148-6","volume":"12","author":"G Li","year":"2015","unstructured":"Li, G. et al. An integrated map of HIV genome-wide variation from a population perspective. Retrovirology 12, 18 (2015).","journal-title":"Retrovirology"},{"key":"3190_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrmicro.2016.182","volume":"15","author":"CJ Houldcroft","year":"2017","unstructured":"Houldcroft, C. J., Beale, M. A. & Breuer, J. Clinical and biological insights from viral genome sequencing. Nat. Rev. Microbiol. 15, 183\u2013192 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"3190_CR38","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1093\/jac\/dkx232","volume":"72","author":"EK Alidjinou","year":"2017","unstructured":"Alidjinou, E. K. et al. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients. J. Antimicrob. Chemother. 72, 2823\u20132830 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"3190_CR39","doi-asserted-by":"publisher","first-page":"e00105","DOI":"10.1128\/JCM.00105-18","volume":"56","author":"PL Tzou","year":"2018","unstructured":"Tzou, P. L. et al. Comparison of an in vitro diagnostic next-generation sequencing assay with Sanger sequencing for HIV-1 genotypic resistance testing. J. Clin. Microbiol. 56, e00105-e118 (2018).","journal-title":"J. Clin. Microbiol."},{"key":"3190_CR40","doi-asserted-by":"publisher","first-page":"O1","DOI":"10.1186\/1471-2334-14-S2-O1","volume":"14","author":"S Mohamed","year":"2014","unstructured":"Mohamed, S. et al. Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure. BMC Infect. Dis. 14, O1 (2014).","journal-title":"BMC Infect. Dis."},{"key":"3190_CR41","volume":"47","author":"G Taiaroa","year":"2024","unstructured":"Taiaroa, G. et al. Characterising HIV-1 transmission in Victoria, Australia: a molecular epidemiological study. Lancet Reg Health West Pac 47, 101103 (2024).","journal-title":"Lancet Reg Health West Pac"},{"key":"3190_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25655","volume":"24","author":"F Di Giallonardo","year":"2021","unstructured":"Di Giallonardo, F. et al. Subtype-specific differences in transmission cluster dynamics of HIV-1 B and CRF01_AE in New South Wales, Australia. J. Int. AIDS Soc. 24, e25655 (2021).","journal-title":"J. Int. AIDS Soc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03190-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03190-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03190-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:09:35Z","timestamp":1751400575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03190-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3190"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03190-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"This study was approved by the St Vincent\u2019s Hospital Human Research Ethics Committee, reference 2022\/ETH01204.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"22057"}}